Resilience Care is raising €48 million from PSG Equity, the sole investor in the round and a new shareholder. The Paris-based company was founded in 2021 in partnership with the Gustave Roussy institute. It develops remote patient monitoring solutions: monitoring software for healthcare professionals and an app for patients. It reports more than 42,000 patients monitored across more than 220 healthcare facilities. The US growth equity fund will support its expansion into Germany and the United States.
Analysis by the experts at Auris Finance, M&A and financial engineering advisory firm.
Resilience Care is approaching €20 million in revenue and is targeting group-level profitability from the second quarter of 2027. It has around 200 employees, including around ten in Germany and nearly five in the United States.
PSG Equity joins existing shareholders Cathay, Singular, Exor, Picus Capital, Red River West, Seaya Ventures, MACSF and Ramsay Santé. These shareholders had invested a total of €68 million since 2021. With this transaction, the total amount raised by the company exceeds €115 million.
A fundraising driven by a consolidation strategy
The company follows a clear rule: three countries and three therapeutic areas. Oncology remains its original business. In May 2026, its gastroenterology solution was already deployed in more than 40 healthcare facilities. In psychiatry, the company has signed around a dozen new partners since the start of the year. Its solution dedicated to mood disorders, Edra, is used in more than 25 French healthcare facilities.
The €48 million will finance this strategy on two fronts: expansion into new therapeutic areas and entry into new markets. The roadmap notably includes the acquisition of companies that already have reimbursement agreements in place. Jonathan Benhamou, co-founder and Chief Executive Officer, explains that he chose PSG Equity for its international support. In both Germany and the United States, the objective combines commercial development and consolidation, with further acquisitions possible.
External growth is already part of Resilience Care’s model. The acquisition of Recovery Cat in the autumn extends a series of acquisitions undertaken by the company.
Recovery Cat, a bridgehead in German psychiatry
In September 2026, Resilience Care acquired the Berlin-based company Recovery Cat. A spin-off from the Department of Psychiatry and Neurosciences at the Charité, it is deployed in nearly 20 hospitals and practices across five federal states. The transaction covers the entire share capital. It combines a cash payment and a share contribution: Recovery Cat’s former shareholders become shareholders in Resilience Care.
The target’s strategic asset is its contract with Techniker Krankenkasse, Germany’s largest health insurance fund, with more than 12 million insured members. Members enrolled in the care pathway use the app free of charge, and participating healthcare professionals are paid for the monitoring. This access is all the more valuable given that, in France, psychiatry does not yet appear on the list of remote monitoring services reimbursed under the standard scheme. The group is now present in 12 healthcare facilities in Germany.
In the United States, Resilience Care has recruited a sales team. In the spring, the company had already reported two recently signed strategic partnerships in this market.
PSG Equity, a shareholder geared towards external growth
PSG Equity invests in software publishers and technology services companies. In September 2026, it closed PSG Europe III, which reached its hard cap with more than €4.4 billion in commitments. The previous fund had raised €2.6 billion. This new vehicle provides portfolio companies with capital and operational support to finance their expansion and acquisitions.
Recent transactions by its portfolio companies illustrate this approach. In October 2026, PSG Equity enabled the combination of QualityHosting, which it has owned since the end of 2025, with Paris-based Be-Cloud. Debt financing supports the combined entity’s acquisition strategy. The same month, the US company MentorcliQ, another PSG portfolio company, acquired the French company Neobrain.
For Resilience Care, the profile of future targets is therefore clearly defined: companies that already have access to reimbursement, like Recovery Cat with its Techniker Krankenkasse contract. The profitability target set for 2027 frames this trajectory.
Our experts at your side
Auris Finance supports business leaders in their M&A and financial engineering transactions.
Are you considering a fundraising, an industrial partnership or a sale in the Healthcare and Life Sciences sector? Our teams are available to support you.
